GC-MS based metabolite fingerprinting of serous ovarian carcinoma and benign ovarian tumor

被引:6
|
作者
Eroglu, Evren Caglar [1 ]
Gulec, Umran Kucukgoz [2 ]
Vardar, Mehmet Ali [2 ]
Paydas, Semra [3 ]
机构
[1] Alata Hort Res Inst, Mersin, Turkey
[2] Cukurova Univ, Med Fac, Dept Gynecol Oncol, Adana, Turkey
[3] Cukurova Univ, Med Fac, Dept Oncol, Adana, Turkey
关键词
metabolomics; biomarker; ovarian cancer; benign tumor; healthy control; GC-MS; OPLS-DA; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; PROSTATE-CANCER; METABOLOMICS; DIAGNOSIS; URINE; SERUM; IDENTIFICATION; PLASMA;
D O I
10.1177/14690667221098520
中图分类号
O64 [物理化学(理论化学)、化学物理学]; O56 [分子物理学、原子物理学];
学科分类号
070203 ; 070304 ; 081704 ; 1406 ;
摘要
The aim of this study is to identify urinary metabolomic profile of benign and malign ovarian tumors patients. Samples were analyzed using gas chromatography-mass spectrometry (GC-MS) and metabolomic tools to define biomarkers that cause differentiation between groups. 7 metabolites were found to be different in patients with ovarian cancer (OC) and benign tumors (BT). R2Y and Q2 values were found to be 0.670 and 0.459, respectively. L-tyrosine, glycine, stearic acid, turanose and L-threonine metabolites were defined as prominent biomarkers. The sensitivity of the model was calculated as 90.72% and the specificity as 82.09%. In the pathway analysis, glutathione metabolism, aminoacyl-tRNA biosynthesis, glycine serine and threonine metabolic pathway, primary bile acid biosynthesis pathways were found to be important. According to the t-test, 29 metabolites were found to be significant in urine samples of OC patients and healthy controls (HC). R2Y and Q2 values were found to be 0.8170 and 0.749, respectively. These results showed that the model has high compatibility and predictive power. Benzoic acid, L-threonine, L-pyroglutamic acid, creatinine and 3,4-dihydroxyphenylacetic acid metabolites were determined as prominent biomarkers. The sensitivity of the model was calculated as 93.81% and the specificity as 98.59%. Glycine serine and threonine metabolic pathway, glutathione metabolism and aminoacyl-tRNA biosynthesis pathways were determined important in OC patients and HC. The R2Y, Q2, sensitivity and specificity values in the urine samples of BT patients and HC were found to be 0.869, 0.794, 91.75, 97.01% and 97.18%, respectively. L-threonine, L-pyroglutamic acid, benzoic acid, creatinine and pentadecanol metabolites were determined as prominent biomarkers. Valine, leucine and isoleucine biosynthesis and aminoacyl-tRNA biosynthesis were significant. In this study, thanks to the untargeted metabolomic approach and chemometric methods, every group was differentiated from the others and prominent biomarkers were determined.
引用
收藏
页码:12 / 24
页数:13
相关论文
共 50 条
  • [21] Ovarian tumor markers of presumed benign ovarian tumors
    Lahlou, N.
    Brun, J. -L.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2013, 42 (08): : 752 - 759
  • [22] Ruptured benign serous ovarian cystadenoma mimicking ovarian malignancy with peritoneal carcinomatosis
    Boussouar, S.
    Fournier, L. S.
    Le-Frere-Belda, M. -A.
    Kao, E.
    Bats, A. -S.
    Chamming's, F.
    DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2016, 97 (11) : 1187 - 1188
  • [23] REIMPLANTATION OF A BENIGN OVARIAN TUMOR
    ASMUSSEN, M
    NIELSEN, MH
    RYGAARD, C
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1988, 67 (05) : 473 - 474
  • [24] Characterization of the molecular differences between ovarian endometrioid carcinoma and ovarian serous carcinoma
    Madore, Jason
    Ren, Fengge
    Filali-Mouhim, Ali
    Sanchez, Lilia
    Koebel, Martin
    Tonin, Patricia N.
    Huntsman, David
    Provencher, Diane M.
    Mes-Masson, Anne-Marie
    JOURNAL OF PATHOLOGY, 2010, 220 (03): : 392 - 400
  • [25] A Comprehensive Review of Ovarian Serous Carcinoma
    Hatano, Yuichiro
    Hatano, Kayoko
    Tamada, Maho
    Morishige, Ken-ichirou
    Tomita, Hiroyuki
    Yanai, Hiroyuki
    Hara, Akira
    ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (05) : 329 - 339
  • [26] NANOG EXPRESSION IN OVARIAN SEROUS CARCINOMA
    Smrkolj, S.
    Suster, N. Kenda
    Virant-Klun, I.
    Grazio, S. Frkovic
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 727 - 727
  • [27] Metastatic Ovarian Serous Carcinoma of the Breast
    Akturk, Guray
    Durak, Merih Guray
    Cakir, Yasemin
    Koyuncuoglu, Meral
    Sevinc, Ali Ibrahim
    Canda, Tulay
    BREAST JOURNAL, 2017, 23 (03): : 362 - 364
  • [28] Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study
    Struck-Lewicka, Wiktoria
    Kordalewska, Marta
    Bujak, Renata
    Mpanga, Arlette Yumba
    Markuszewski, Marcin
    Jacyna, Julia
    Matuszewski, Marcin
    Kaliszan, Roman
    Markuszewski, Michal J.
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2015, 111 : 351 - 361
  • [29] Comparative Metabolite Fingerprinting of Four Different Cinnamon Species Analyzed via UPLC-MS and GC-MS and Chemometric Tools
    Farag, Mohamed A.
    Kabbash, Eman M.
    Mediani, Ahmed
    Doll, Stefanie
    Esatbeyoglu, Tuba
    Afifi, Sherif M.
    MOLECULES, 2022, 27 (09):
  • [30] Identification of stably expressed microRNAs in plasma from high-grade serous ovarian carcinoma and benign tumor patients
    Petersen, Patrick H. D.
    Lopacinska-Jorgensen, Joanna
    Hogdall, Claus K.
    Hogdall, Estrid V.
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (12) : 10235 - 10247